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Summary 
To investigate the role of TNFc~ in the development of in vivo immune responses we have 
generated TNFoL-deficient mice by gene targeting. Homozygous mutant mice are viable and 
fertile, develop lymph nodes and Peyer's patches and show no apparent phenotypic abnormali- 
ties,  indicating that TNFoL is not required for normal mouse development. In the absence of 
TNFcx mice readily succumb to L.  monocytogenes infections and show reduced contact hyper- 
sensitivity responses. Furthermore, TNFot knockout mice are resistant to the systemic toxicity 
of LPS  upon  r)-galactosamine  sensitization, yet they remain  sensitive to  high  doses  of LPS 
alone. Most interestingly, TNFcx knockout mice completely lack splenic primary B cell follicles 
and  cannot  form  organized  follicular dendritic  cell  (FDC)  networks  and  germinal  centers. 
However, despite the absence of B cell follicles,  Ig class-switching can still occur, yet deregu- 
lated humoral immune responses against  either thymus-dependent (TD) or thymus-indepen- 
dent (TI) antigens are observed. Complementation of TNFc~ functioning by the expression of 
either human or murine TNFo~ transgenes is sufficient to reconstitute these defects, establishing 
a physiological role for TNFc~ in regulating the development and organization of splenic follic- 
ular architecture and in the maturation of the humoral immune response. 
T 
umor necrosis factors (TNFcx and TNF[3 or lympho- 
toxin-or [LTo~]  1) are known to be critically involved in 
the regulation of infectious, inflammatory and autoimmune 
phenomena (1).  TNFo~ is produced in response to various 
stimuli mainly by macrophages and T  cells and is shown to 
be bioactive both as a transmembrane protein and as a ho- 
motrimeric secreted molecule  (2).  LToL, originally identi- 
fied as a major product oflymphocytes, exists as a secreted 
molecule only in a homotrimeric form (3), but it may also 
accumulate  on  the  cellular  membrane  when  complexed 
with LT[3, a type II transmembrane protein that is another 
member of the TNF ligand family (4). LTot[3 signals exclu- 
sively through ,he  LT[3  receptor(s)  (5)  while  TNFot and 
1Abbreviations used in this paper: CH, contact hypersensitivity;  DAB, di- 
aminobenzidine; ES, embryonic  stem; FDC, follicular  dendritic cell; GC, 
germinal centers; LH, Limulus hemocyanin;  LTcx,  lymphotoxin-oq  PNA, 
peanut agglutinin; S-AP, streptavidin-alkaline  phosphatase; TD, T cell- 
dependent; Tl, T cell-independent. 
LTor share the same cell surface receptors, designated p55 
and p75 TNF-R, which show common but also differen- 
tial activities depending on the cell type in which they op- 
erate (6). p75 TNF-R signaling has been mainly implicated 
in lymphocyte proliferation (7, 8) whereas the p55 TNF-R 
is  generally known to mediate apoptosis  (9),  a process in 
which the p75 TNF-R may also be involved (10,  11). 
The generation  of mice  deficient for TNF-R.s  and for 
LTo~ has  confirmed  the  idea  that  these  molecules  serve 
specific and important immunoregulatory functions. Mice 
lacking the p55 TNF-1L are resistant to the lethal effects of 
low doses oflipopolysaccharides (LPS), show increased sus- 
ceptibility to infection with Listeria  monocytogenes  (12,  13) 
and enhanced reactivity against  contact allergens (14), indi- 
cating the essential  role of the p55  TNF-R. in LPS-medi- 
ated  systemic toxicity, anti-bacterial  host  defense mecha- 
nisms  and  contact hypersensitivity reactions.  Surprisingly, 
targeted knockout of the murine LTot gene disrupts the de- 
velopment of lymph nodes and Peyer's patches and results 
in a disturbed splenic architecture characterized by the ab- 
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lacking the p55  TNF-R  show  a  complete lack of Peyer's 
patches (16), yet they develop lymph nodes, suggesting that 
the organogenetic role of LTe~  involves signaling through 
the LT[3-1L for the genesis of lymph nodes, and seemingly 
through the p55 TNF-R  for the genesis of Peyer's patches. 
More recently, LTcx-deficient mice were also found defec- 
tive  in  the  formation  of germinal  centers  (GC)  (17),  but 
because of the inherent dominant perturbation of the lym- 
phoid system in these mice, a direct role for LTo~ signaling 
in  germinal  center  reactivity could  not  be  demonstrated. 
Moreover, in analogous knockout systems, the presence of 
the  p55  TNF-R,  but  not  of the  p75  TNF-R,  was  also 
found to be essential for the development of germinal cen- 
ters  (17),  yet again, a  conclusive answer as to whether  ei- 
ther or both LTec and TNFe~ contribute to this phenome- 
non, could not be reached. 
To  obtain  definitive answers  on  the  individual role  of 
TNFe~ in the development and physiology of the immune 
system,  we  have  used  gene  targeting  in  embryonic  stem 
(ES) cells to generate a TNF~x-deficient mouse strain. Our 
findings demonstrate the important in vivo role of TNF~x 
in LPS toxicity, contact hypersensitivity reactions and im- 
mune  reactivity against pathogens.  Furthermore,  they  es- 
tablish a critical requirement for this factor in processes reg- 
ulating the formation of primary B  cell follicles, follicular 
dendritic cell (FDC) networks and germinal centers and in 
the  physiological maturation  of the  humoral  immune  re- 
sponse. 
Materials and Methods 
Generation  of TNFa Knockout Mice.  The  genomic  locus con- 
taining the genes for TNFet and LTot was isolated from a 129/Sv 
mouse genomic library in kFIX~II (Stratagene Inc., La Jolla, CA) 
(18).  The targeting vector was constructed by replacing with an 
MClneopA cassette (Stratagene) the 438-bp NarI-BgllI fragment 
containing 40 bp of the 5' UTR, all the coding region, including 
the ATG translation initiation codon, of the first exon and part of 
the  first  intron  of the  muTNFo~  gene.  The  neo  cassette  was 
flanked by 4.5 and 1.2 kb of homologous sequences, respectively. 
A thymidine kinase (tk) gene under the control of the MC1 pro- 
moter (19) was inserted at the 5'  end of the targeting vector for 
negative selection against random integrations. The targeting vec- 
tor (25 p~g) was linearized and electroporated into CCE embryonic 
stem cells (20).  Electroporation and selection were performed as 
previously described (21) and targeted clones were identified by 
Southern  blot  analysis  using  the  external  ScaI-EcoRI  probe 
shown in Fig. 1 a. The frequency of homologous recombination 
was 1 in 48 double drug resistant colonies. Chimeric mice were 
produced by microinjection of embryonic stem cells from four 
different targeted clones into C57B1/6 blastocysts. Male chimeras 
were mated to C57B1/6 females and germ line transmission of the 
mutant TNFe~ gene in agouti progeny was confirmed by South- 
ern-blot analysis  of tail DNA.  Germ line transmission was  ob- 
tained from two out of four clones injected. Heterozygous mice 
were  intercrossed and homozygous mice  were  obtained at  the 
predicted frequency. 
Northern  Blot Analysis of Macrophage RNA.  Mice were injected 
intraperitoneally with 1 ml of a 4% thioglycollate medium (Difco 
Labs.,  Detroit, MI)  and 3  d  later peritoneal exudate cells were 
harvested by peritoneal lavage with  5 ml ILPMI  1640  medium 
supplemented with 5% FCS (GIBCO BRL, Gaithersburg, MD). 
Cells were  cultured for  1 h  at 37~  5%  CO2  in tissue  culture 
petri dishes and were washed twice with medium to remove non 
adherent  cells.  Adherent  macrophages  were  cultured  with  or 
without LPS (1  I~g/ml) for 1 h  and RNA was isolated with the 
method  of guanidinium thiocyanate  (22).  Total R.NA  (15  ~g) 
was resolved in 1% formaldehyde agarose gel, blotted onto Hy- 
bond N + nylon membrane (Amersham Corp., Arlington Heights, 
IL) and hybridized with a 32p-labeled EcoRI-NarI genomic probe 
containing part of the first  exon of the muTNFcx gene.  Mem- 
branes were stripped and rehybridized with a neo probe. 
Measurement  of Serum  TNFa  and  IL-I~  in  LPS-induced  Septic 
Shock.  Mice  were  injected  intraperitoneally with  1  mg  LPS 
(Salmonella  enteritidis,  L-6011; Sigma Chem. Co., St. Louis, MO) 
and sera were collected 90 min and 4 h later. Levels of TNFot in 
the serum of wild-type and homozygous mutant mice 90 min af- 
ter  LPS  challenge  were  measured  with  a  muTNF~  specific 
ELISA provided by Dr. Wire Buumlan  (University of Limburg, 
The  Netherlands)  (23).  Levels of IL-1]3 were  measured in sera 
collected 4  h  after LPS injection using a murine  IL-I[3 ELISA 
(Endogen Inc., Boston, MA). 
LPS-induced Septic Shock.  Mice  (10-12  wk  of age)  were  in- 
jected intraperitoneally with the indicated amounts of LPS (Sal- 
monella enteritidis; Sigma L-6011) and D-Galactosamine (Sigma) in 
0.2 ml of sterile phosphate-buffered saline. 
Listeria Infection,  Mice were  infected intravenously or intra- 
peritoneally with  104  CFU  of Listeria  monocytogenes  strain L028 
(24, 25). For bacterial counts mice were killed 4 d after infection and 
numbers of viable bacteria were determined by plating serial dilu- 
tions of liver and spleen homogenates in saline on BHI agar plates. 
Contact Hypersensitivity  Test.  To test contact sensitivity to ox- 
azolone,  100  p.1 of a 4% solution of 4-ethoxymethylene-2-phe- 
nyl-2-oxazolin-5-one (oxazolone, E-0753; Sigma) in acetone was 
applied on the shaved mouse abdomen and allowed to dry on the 
skin. 5 d later mice were challenged by painting both sides of one 
ear with 50 pA of 1% oxazolone in acetone, leaving the other ear as 
a control. Mice were killed 24 h after treatment and a disk of ear 
tissue was removed from both ears of each mouse using a 6-ram 
biopsy punch, and weighed. Swelling was measured as the differ- 
ence  in weight between  the  painted and  the  unpainted ear of 
each mouse. In each experiment, a group of non-sensitized mice 
was included to  measure  the  swelling occurring after ear chal- 
lenge without prior sensitization. The results are expressed as the 
weight gain of the challenged versus the non-challenged ear -+ 
SE for each group and the data were analyzed by student's t test. 
Immunization  of Mice.  To induce antibody responses to the T 
cell-dependent (TD)  antigen SRBC, mice were immunized in- 
traperitoneally with 10  s SRBC on day 0 and day 15. Mice were 
bled on day 7,  14, and 23 for measurement of anti-SRBC serum 
antibodies. Sera obtained from similar groups of non immunized 
mice matched for genotype, age and sex were used as controls for 
pre-immune anti-SRBC values. For generation of antibody re- 
sponses  to a different TD  antigen, mice were immunized intra- 
peritoneally with 50 p~g TNP-KLH in complete Freund's adjuvant 
on day 0  and boosted with an intraperitoneal injection of 5 p,g 
TNP-KLH in PBS on day 28. Mice were bled 7, 20, and 35 d af- 
ter primary immunization for measurement of anti-TNP serum 
antibodies. To induce antibody responses to T  cell-independent 
(TI) antigens mice were immunized intraperitoneally with 50 I.Lg 
of TNP-LPS (T-7268; Sigma) or 25 ~g of TNP-Ficoll in PBS on 
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rum antibodies. 
ELISA for SRBC  or TNP-specific Serum Antibodies.  Sera  from 
immunized mice  were  assayed  using TNP-specific  ELISA  for 
IgM, IgE, IgG1, IgG2a, IgG2b, and IgG3 antibodies. In brief, 96- 
well  flat-bottomed  Immuno-Maxisorp plates  (Nunc,  Roskilde, 
Denmark) were coated by adding 100 Izl/well of 10 Izg/ml TNP- 
bovine serum albumin in carbonate buffer (pH 9.6)  overnight at 
4~  Plates were washed with deionized water and blocked with 
2 mg/ml BSA (150 Ixl/well) in PBS for 1 h  at 37~  Plates were 
washed  three  times with PBS  containing 0.05%  Tween 20 and 
serum samples diluted in PBS  containing 0.05% Tween 20,  1% 
BSA and 1 M  NaC1 were added in duplicate wells (100 ~l/well) 
and incubated for 1 h  at 37~  For the determination of IgM an- 
tibodies,  samples  were  incubated with  Horseradish  Peroxidase 
conjugated goat anti-mouse IgM (Sigma) (100 gU/weU,  1:10,000 
dilution in PBS containing 1% BSA) for 1 h at room temperature. 
For measurement of IgE antibodies, samples were incubated with 
a monoclonal rat anti-mouse IgE antibody (Serotec, Kidlington, 
England) (2 I~g/rnl in PBS 1% BSA, 100 I~l/well) for 1 h  at room 
temperature  followed by incubation with  a  horseradish peroxi- 
dase conjugated goat anti-rat IgG antibody (Sigma). For the de- 
termination of IgG1,  IgG2a,  IgG2b,  and IgG3 antibodies plates 
were incubated with peroxidase-labeled goat anti-mouse IgG sub- 
class-specific antibodies (Southern Biotechnology, Birmingham, 
AL) (1:5,000 dilution in PBS containing 1% BSA). Measurements 
of TNP-specific total IgG antibodies were performed using a per- 
oxidase-labeled goat anti-mouse IgG antibody (Sigma). All ELI- 
SAs were developed with 0.4 mg/ml 0-phenyldiamine dihydro- 
chloride  (Sigma)  in  0.05  M  phosphate-citrate  buffer,  pH  5.0, 
containing 0.03% H202, stopped with 50  Ixl of 2  M  H2SO  4 and 
0D490 was measured using an MRX microplate Reader (Dyna- 
tech  Labs.,  Chantilly, VA).  Serum anti-SRBC  antibodies were 
measured by SRBC-specific isotype ELISAs. Briefly, 96-well flat- 
Figure 1.  Inactivation of the TNFct gene by homologous  recombina- 
tion in ES cells. (A) Structure of the murine genomic locus containing  the 
genes for TNFet and LTct, the targeting construct and the predicted re- 
combinant allele generated  by the  homologous  recombination.  Closed 
boxes indicate coding regions and open boxes indicate 5' and 3' untrans- 
lated regions of exons. Arrows show the transcriptional orientation of neo 
and tk  expression cassettes. RI,  Nr,  Bg and Sc  indicate  EcoRI,  NarI, 
BgllI, and ScaI restriction sites respectively. (B) Southern blot analysis of 
EcoRI-digested  tail DNA from wild-type  (+/+),  heterozygous  (+/-) 
and homozygous  (-/-)  mutant mice using the ScaI-EcoRI  probe. The 
wild-type  allele produces a 2.8-kb band while in the targeted allele the 
acquisition of a new EcoRI site produces a band of 1.6 kb. (C) Northern 
blot analysis of RNA from thioglycollate elicited uninduced (-) or LPS- 
induced (+) peritoneal macrophages obtained from wild-type,  heterozy- 
gous, and homozygous  TNFct knockout mice.  Hybridization  using the 
0.8-kb EcoRI-NarI 5' muTNFot genomic fragment containing part  of 
the first exon of muTNFet gene as a probe,  confirmed the presence of a 
single 1.9-kb  hybridizing band in wild-type macrophages, representing 
the wild-type TNFet mRNA. This transcript was absent in macrophages 
from homozygous mutant mice. Instead two higher molecular weight hy- 
bridizing  transcripts  were  observed.  Macrophages  from  heterozygous 
mice express all three kinds of transcripts. Reprobing of the same mem- 
brane with a neo probe showed that the novel transcripts contain the neo 
sequences which disrupt the TNFet mRNA. 
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were coated by adding 100 Ixl/well of a solubilized extract  from 
SRBC (26) (5 Ixg/ml in carbonate buffer, pH 9.6). After incuba- 
tion at 4~  overnight, plates were washed  and blocked with 1% 
BSA in PBS for 2 h at 37~  Serum samples diluted in PBS con- 
taining 0.05% Tween 20,  1% BSA and 1 M NaC1 were added in 
duplicate  wells  (100  Ixl/well)  and incubated overnight at  RT. 
Bound antibodies were detected as described above for the TNP- 
specific ELISAs. 
Immunocytochemical  Analysis of Splenic Struaure.  Spleens  from non- 
immunized mice were embedded in O.C.T. compound (BDH) 
and frozen in liquid nitrogen. Sections  were  cut on a cryostat, 
thaw-mounted on gelatinized slides, air dried,  and then stored at 
-20~  Immediately before use sections were fixed for 10 rain in 
acetone containing 0.03% H202 to block endogenous peroxidase 
activity.  For double immunostaining  for IgM and IgD, sections 
were rehydrated  in PBS  and incubated with peroxidase-labeled 
goat  anti-mouse IgM  (Sigma) and biotin-conjugated rat  anti- 
mouse IgD (Southern Biotechnology, Birmingham, ALl antibod- 
ies for 2 h at RT, followed  by streptavidin-alkaline phosphatase 
(S-AP) (Vector Labs., Inc., Burtingame, CA). Bound peroxidase 
activity  was detected by staining with diaminobenzidine (DAB; 
Sigma), alkaline phosphatase  activity  was visualized with NBT- 
BCIP (GIBCO BILL) and slides were embedded with glycerol- 
PBS.  For anti-CD3 and anti-FDC staining sections  were incu- 
bated with  a rat  anti-mouse CD3  monoclonal antibody (clone 
KT3 [27], kindly provided by Dr. S. Cobbold, Sir William Dunn 
School  of Pathology,  Oxford,  UK) or with the FDC-M1  anti- 
body (specific for mouse follicular dendritic cells [28], kindly pro- 
vided by Dr. M. Kosco-Vilbois,  Glaxo Institute for Molecular Bi- 
ology,  Switzerland).  Subsequently, sections were incubated with 
biotin-conjugated anti-rat lgG antibody (Vector Labs., Inc.) fol- 
lowed by S-AP, and developed with NBT-BCIP. 
For the analysis of germinal center formation mice were im- 
munized with an intraperitoneal injection of 10  s sheep red blood 
cells (SILBC) and spleens were removed 8 d later,  embedded in 
O.C.T. compound (BDH),  and frozen in liquid nitrogen. Cryo- 
stat sections were fixed in acetone and incubated with 0.5% H202 
in methanol for 30  rain at room temperature to block endoge- 
nous peroxidase activity. Sections were rehydrated  with PBS, in- 
cubated with 20 txg/ml peanut agglutinin-horseradish peroxidase 
(Sigqna) in PBS-BSA  0.1% for 2 h at room temperature, washed 
and stained with diaminobenzidine  (Sigma). Sections were subse- 
quently  incubated  with  a  biotin  conjugated  rat  anti-mouse 
CD45IL/B220 antibody (PharMingen, San Diego, CA) for 3 h at 
room temperature followed by S-AP (Vector Labs.). Bound alkaline 
phosphatase  activity  was  visualized  with  NBT-BCIP  (GIBCO 
Table  1.  ELISA Analysis of TNFoe and IL- 1t8 Levels After 
LPS Induction 
Genotype  TNFoe (ng/ml)  IL-I[B (ng/ml) 
Wild-type  7.88  •  1.31  0.84  •  0.22 
TNFo~  -/-  0.00  +  0.00  0.74  -+ 0.06 
TNFoe-deficient  nfice and wild-type controls (n =  7 for both groups) 
were injected intraperitoneally  with 1 mg LPS and were bled 90 min 
and 4 h later. Serum levels of TNF(x at 90 rain and oflL-113 at 4 h after 
LPS  injection were deternfined with  specific ELISAs. The  data are 
means -+ SE per group. 
Table 2.  Measurements of LPS-induced Lethality in TNFee 
Knockout Mice 
Dose  Lethality (deaths/total) 
LPS  D-Galactosamine  TNFo~  +/+  TNFc~  -/- 
Ng  mg 
1,200  --  3/5  3/5 
100  --  0/3  (J/3 
100  20  5/5  0/5 
10  20  5/5  0/5 
1.0  20  5/5  0/5 
0.1  20  5/5  0/5 
0.01  20  2/5  0/5 
Mice (1(>-12 wk of age) were injected intraperitoneally  with the indi- 
cated amounts of LPS (Salmonella enteritidis, L-6011; Sigma) and D-Galac- 
tosamine (Sigma) in (3.2 ml of sterile phosphate-buffered saline. The 
dose of LPS was calculated  per 20 g of body weight. Survival  was mon- 
itored for 7 d. 
BILL) and slides were embedded with glycerol-PBS.  Slides were 
photographed using a Nikon Diaphot 300 microscope. 
Results and Discussion 
Generation of TNFa-Deficient Mice.  To investigate the in- 
dividual role of TNFc~ in the regulation of the immune re- 
sponse we  have  generated TNF(x-deficient mice by gene 
targeting in ES  cells  (Fig.  1,  a  and  b).  Disrupted  TNFR 
mILNA expression in homozygous mutant mice was con- 
firmed by Northern analysis of tLNA isolated from  LPS- 
stimulated macrophages (Fig.  1 c). The functional inactivation 
of the TNFc~ gene was further confirmed by the absence of 
TNFo~ protein in sera from LPS-injected homozygous knock- 
out mice, as measured by a murine TNFc~-specific ELISA 
(Table 1). Furthermore, no TNFa bioactivity could be de- 
tected in sera from LPS-injected TNFot  -/- mice and super- 
natants from LPS-induced TNFcl  -/- macrophages, as mea- 
sured  by  standard  L-929  cytotoxicity  assays (not  shown). 
Homozygous  TNFcx  -/- mice  are  viable  and  fertile  and 
show no apparent phenotypic abnormalities, indicating that 
TNFc~ expression is not required for normal mouse devel- 
opment. However, in contrast to the LTot and p55TNF-R 
knockout  mice,  lymph  nodes  and  Peyer's  patches  could 
readily be  detected  in TNFot  knockout mice,  suggesting 
that TNFci is not necessary for lymphoid organogenesis. 
TNFa Knockout Mice are Resistant to  the Systemic Toxicity 
of LPS.  The critical role of TNFs in the lethal endotoxin 
shock syndrome has been addressed in several studies em- 
ploying neutralizing anti-TNF strategies  (29-31)  or,  more 
recently, in TNF-R  knockout mice (12,  13).  Using stan- 
dard  D-Galactosamine (D-GaIN)  sensitization in mice  we 
could show that at doses as high as 100 txg ofLPS, TNFe~  -/- 
mice remain completely resistant to shock and death, while 
at even 1,000-fold lower doses all nomaal control mice die 
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Figure  2.  Kole  of  TNF~x  in 
host  defense  to  L.  monocytogenes. 
TNFot +/+  (O),  TNF~x -/-  (V]), 
TNFot -j-  X  Tg  A86  (A)  and 
TNFc~  -/-  ￿  Tg  1278  (V),  (A) 
Bacterial  burden  in  liver  and 
spleen.  Mice  were  infected  intra- 
peritoneally  with  104  CFU  of L. 
monocytogenes and numbers of via- 
ble  bacteria  in  liver  and  spleen 
were  determined  4  d  later.  (B) 
Lethality  after  L.  monocytogenes 
challenge.  TNFcC/+  (n  =  16), 
TNFIx  -/-  (n  =  18),  TNFIx  -/-  ￿ 
Tg A86  (n  =  15),  and  TNFcx -/- 
￿  Tg 1278  (n =  4) mice were in- 
oculated intraperitoneally with  104 
CFU  of bacteria  and  survival was 
monitored for 10 d. 
(Table 2). These results  establish  the pivotal role of TNFo~ 
in  mediating  endotoxin  lethality  in  D-GalN  sensitized 
mice.  However, high  doses  of LPS alone  (1,200  ~g)  are 
found to be equally lethal for both TNFoU-  and control 
mice, indicating that other factors produced independently 
of TNFot,  mediate  toxicity  in  this  model  of endotoxic 
shock.  Recent  studies  in  interleukin-l[~  converting  en- 
zyme knockout mice suggest that IL-1 may play a role in 
these  processes  (32).  Consistent  with  this  hypothesis  we 
could show that 4 h after LPS-challenge, a normal level of 
IL-113 production is detected in sera  from TNFot  -/- mice 
(Table 1), suggesting that IL-I~ is produced independently 
of TNFo~ upon high dose LPS stimulation. 
Deficient Anti-Bacterial Responses in  TNFa Knockout Mice 
Rescued by Expression of a  Transmembrane TNFa  Transgene. 
Earlier  studies  on  TNF  receptor-deficient mice  (12,  13) 
have  demonstrated the  critical role of p55  TNF  receptor 
signaling in host defense, in particular during infection with 
the intracellular bacterium Listeria monocytogenes. To estab- 
lish the individual role of TNFIx in this system, TNFo~ -/- 
mice and wild-type controls were challenged with an intra- 
peritoneal injection of 104 colony-forming units (CFU) of 
Listeria monocytogenes. 4  d  after infection, TNFix-deficient 
mice exhibited 10,000-100,000 fold higher bacterial titters 
in their hvers and spleens in comparison to controls (Fig. 2 a). 
Moreover, by day 6  after infection 18/18  of TNFoL-defi- 
cient mice and 0/16 of the controls had died (Fig. 2 b). Sim- 
ilar results were obtained when bacteria were administered 
intravenously.  These  results  demonstrate  a  critical  role for 
TNFo~  in  orchestrating host  reactivity against  pathogenic 
bacteria. 
To dissect  further the individual role of the soluble and 
transmernbrane forms of TNFo~  in anti-bacterial host de- 
fense, we have sought to restore the TNFot deficiency of the 
TNFIx  -/-  mice by breeding them with TNFci transgenic 
mouse lines expressing either wild-type or uncleavable mu- 
tant  TNFc~ proteins.  Two different transgenic lines were 
used:  Tg1278  mice  (33)  expressing  a  wild-type  human 
TNFlx  transgene  in  several  of their  tissues  including  the 
macrophages,  and  TgA86  mice  (unpublished  data),  simi- 
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larly  expressing  in  their  tissues  a  mutant  murine  TNF0t 
gene made by the deletion of the triplets encoding the first 
12  amino  acids  of the  mature  TNF~x  protein.  This latter 
transgene does not produce any measurable bioactive TNFot 
protein in sera from LPS-treated, double TgA86 ￿  TNFoU- 
mice, or in supematants from LPS-induced macrophages ob- 
tained  from  these  mice  (not  shown).  A  similar  mutant 
TNFo~ gene has been recently shown to produce bioactive 
transmembrane  TNFot  protein  but  no  bioactive  soluble 
TNF(i when transfected in cultured cells  (34,  our unpub- 
lished  results).  Both  double  TNFel  -/-  ￿  Tg1278  and 
TNFoL  -/-  ￿  TgA86 mice were able  to control infection 
when  challenged  with  104 CFU  Listeria monocytogenes as 
shown by  100-1,000-fold  reduced bacterial  counts  mea- 
sured 4 d after infection, in comparison to similarly treated 
TNFoU- mice (Fig. 2 a). Furthermore, by day 10 after in- 
g 
Ill 
Non-Sensitized  Sensitized  Non-Sensitized  Sensitized 
+/+  ./_ 
Figure  3.  Hypersensitivity  to  contact  allergen  oxazolone.  Wild-type 
controls  (+/+)  and  TNFc~  knockout  (-/-)  mice  (n  =  8  for  both 
groups) were either sensitized with application of oxazolone on the skin 
(closed bars) or left untreated (open bars). 5 d later mice were challenged by 
painting oxazolone  on one  ear leaving the  other  ear as  a  control.  The 
contact hypersensitivity reaction was measured as the weight gain of the 
treated versus the untreated  ear of each mouse 24 h  later as described in 
the experimental procedures.  The  data are expressed as mean  +  SE per 
group (sensitized,  +/+  versus -/-mice,  P  <0.001  by student's t test). 
This experiment was repeated twice with similar results. Figure 4. 
fection, most of the TNFc~ transgene-reconstituted knock- 
out mice survive infection, while all TNFot-deficient mice 
die (Fig. 2 b). The small percentage of double TNF~x -/-  X 
TgA86  transgenic  mice which finally succumb to Listeria 
infection may be associated with the incomplete clearance 
of  bacteria observed in these mice in comparison to normal 
controls (Fig. 2 a). This apparently partial complementation 
of TNFo~ functioning may be due to deviations from nor- 
real  patterns  of TNFcx  expression inherent  to  transgenic 
systems. Taken together, these results demonstrate that TNFcx 
is indispensable for immune homeostasis during anti-microbial 
responses.  Furthermore,  based  on  the  shown  inability  of 
the  human  TNF  to  bind and  signal  through  the  murine 
p75TNF-R (35),  the observed ability of human TNFcx to 
rescue a compromised host defense in the TNF~x -/- mice, 
confirms that TNFo~ signaling through the p55 TNF-R is an 
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finding  that  transmembrane  TNFot  is  sufficient  to  rescue 
deficient anti-bacterial responses in TNFct  -/- mice, estab- 
lishes a direct in vivo role for cell contact-mediated TNFot 
signaling in the regulation of host defense against pathogens. 
TNFa Knockout Mice Show Impaired Contact Hypersensitiv- 
ity Responses.  A role for TNFct has been proposed in me- 
diating contact hypersensitivity (CH)  reactions.  Studies  in 
routine  models  of CH  using  neutralizing  anti-TNF  anti- 
bodies  have  been  controversial,  indicating  either  an  en- 
hancing  (36-38)  or  an  immunosuppressive  (14)  role  for 
TNF0t  in  CH reactions.  However, mice deficient for the 
p55  TNF-tk  show  enhanced  contact  hypersensitivity  re- 
sponses, suggesting an immunosuppressive role for this re- 
ceptor  in  CH  (14).  In  contrast,  an  enhancing  role  for 
TNFct-mediated p75  TNF-R signaling in  contact sensiti~ 
1403  Pasparakis  et al. Figure 4.  Absence of primary B ceil follicles and FDC networks from the spleens of non-immunized TNFct knockout mice. Serial sections from nor- 
real mice stained with anti-IgM (brown)  and anti-IgD (blue)  (a),  or with an anti-CD3 antibody (blue)  (c) reveal the existence  of clearly defined  T cell-rich 
PALS (7), primary B cell follicles (F), marginal  zone (M} and red pulp areas (R). Arrowheads denote central arterioles.  Similar staining of serial sections 
from TNFot knockout mice (b and d) reveal the absence of primary B cell follicles while T  cell-rich PALS and marginal zone areas appear normal, FI)C 
networks (arrows) organized inside primary B cell follicles (F) are detected in sections from normal (e) but not from TNlaot -/- mice (f) stained with the 
FDC-M1  antibody. Original magnifications  X100 for a-d and X200 for e andf. 
zation  has  been  proposed  in  studies  showing  murine  but 
not  human  TNFot  to  stimulate  routine  epidermal  Langer- 
hans  cells  (LC)  to  migrate  from  the  skin  to  the  draining 
lymph nodes after allergen application  (38,  39).  To  address 
the  role  of TNF~x  in  CH,  we  have  characterized  the  re- 
sponse  of TNFot  knockout  mice  against  the  contact  aller- 
gen oxazolone.  Mice were sensitized by application of oxa- 
zolone  on  the  abdominal  skin,  and  5  d  later,  they  were 
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sponse was measured 24 h  later as the weight gain of the 
oxazolone-painted ear versus the untreated ear. In this as- 
say, TNFet knockout mice showed a significant (P <0.001) 
decrease in the hypersensitivity response, observed as a 33% 
reduction in ear swelling compared to the wild-type con- 
trols (Fig. 3). These results show that TNFot is necessary for 
optimal  contact  sensitization  and  establish  an  overall en- 
hancing  role  for  TNFot  in  contact  hypersensitivity  re- 
sponses. 
TNFa-deficient Mice Lack Primary B Cell Follicles and Orga- 
nized FDC Networks.  Splenic white pulp consists  of three 
major  compartments:  (0  periarteriolar  lymphoid  sheaths 
(PALS)  containing mainly T  cells and interdigitating den- 
dritic cells,  (i0 primary B  cell follicles  consisting of a net- 
work of follicular dendritic cells (FDC) and naive recircu- 
lating IgM +,  IgD + B  cells,  and  (iiO the  marginal  zone, a 
layer containing reticular cells,  macrophages  and  resident 
IgM +,  IgD- B  lymphocytes that surrounds the PALS and 
follicular areas (Fig. 4 a, c, and e). Recent evidence, has im- 
plicated LTa and the p55TNF-R as important regulators 
of splenic  microarchitecture. LTo~ knockout mice are found 
defective in all of the components which are characteristic 
of the presence of lymphoid tissue in the spleen. They lack 
distinct B  and T  cell areas and marginal zone markers (15, 
17).  In  contrast to  the  LTot knockout mice, p55  TNF-R 
knockout mice show distinct B  and T  cell areas, yet upon 
immunization they lack organized FDC networks (40). 
To determine whether TNFot is involved in these activ- 
ities  we  have  examined  splenic  structure  in  non-immu- 
nized  TNFot-deficient mice.  Double  immunostaining  of 
TNFot  -/- spleen sections with anti-IgM and anti-IgD anti- 
bodies revealed the absence of distinct primary B cell folli- 
cles.  Instead,  a thin layer of IgM  +,  IgD §  B  cells was  ob- 
served forming perimetrically underneath the marginal zone 
(Fig.  4 b). In addition, staining of spleen sections with the 
FDC-M1  antibody, a  marker for follicular dendritic cells 
(28), failed to reveal the presence of FDC networks in TNFcx 
knockout  mice  (Fig.  4 f).  However,  anti-CD3  staining 
showed  the  presence  of normal  T  cell-rich  PALS  areas 
(Fig. 4 d). Moreover, similarly to the TNFo~ knockout mice, 
p55TNF-R-deficient mice (provided by Dr. Horst Blueth- 
mann, Hoffman LaRoche, Switzerland) were also found to 
lack  organized primary B  cell follicles  (data  not  shown). 
Taken together, these results show an absolute requirement 
for TNFcx signaling through the p55TNF-P,, in the correct 
development and organization of structured B  cell follicles 
and FDC. 
Deficient  Germinal Center  Formation  in  TNFa  Knockout 
Mice.  To investigate the  functional consequences of the 
primary B  cell follicle deficiency, we  have  followed the 
ability  of TNFcx  -/- mice  to  develop FDC  networks  and 
germinal centers in their spleens after intraperitoneal im- 
munization  with  T  celt-dependent  antigens  i.e.,  SP,.BC, 
TNP-KLH  in  CFA,  and  Limulus  hemocyanin  (LH)  in 
CFA.  Immunocytochemical staining of frozen spleen sec- 
tions with either FDC-M1  (Fig.  5 a) or peanut agglutinin 
(PNA), a specific marker of germinal center cells (41) (Fig. 
5  c), showed the  existence of typical FDC  networks  and 
germinal centers forming within follicles in wild-type con- 
trol  mice.  In  sharp  contrast,  a  striking  absence  of both 
FDCs (Fig. 5 b) and typical germinal centers (Fig. 5 d) was 
observed  in  spleens  from  immunized  TNFec  -/-  mice, 
where  only  some  PNA-positive  cells  could  be  detected 
around arterioles inside the T  cell-rich PALS. 
Complementation of TNFot functioning by the expres- 
sion  of a  wild-type  human  TNFcx  transgene  in  double 
TNFoU-  ￿  Tg1278 mice is sufficient to partly reconsti- 
tute the formation of FDC networks and germinal centers. 
Most of the  germinal centers seen in the spleens of such 
mice are found to form ectopically around  arterioles and 
within the T  cell-rich PALS (Fig. 5 e). In contrast,  expression 
of murine transmembrane TNFot in the double TNFet  -/-  ￿ 
TgA86  mice  is  sufficient  to  completely rescue  deficient 
FDC  and  germinal center formation in  TNFix knockout 
mice (Fig.  5 J0.  It seems therefore that human TNFot sig- 
naling  is  sufficient to  drive  GC  formation in  the  TNFot 
knockout mice. Since human TNFot only binds to the rnu- 
rine p55TNF-R and not to the murine p75TNF-P, (35), 
this result  indicates  that signals through the p55TNF-R but 
not the p75TNF-R are essential  for the formation of B cell 
follicles,  FDC networks and germinal centers. The latter, is 
further  supported  by  recent  findings  of morphologically 
normal GC in p75 TNF-R knockout mice (17). 
The critical importance of LTot and p55 TNF-R signal- 
ing in germinal center formation has  been recently estab- 
lished in mutant mice (17).  However, a conclusive answer 
as to whether LTo~ mediates this effect through p55 TNF-R. 
or LT[3-R signaling,  could not be reached.  As  shown  in 
this study, TNFot signaling through the p55TNF-P, is re- 
quired for the development of primary B  cell follicles and 
germinal centers. Assuming that in the LTot-deficient mice, 
TNFcx signaling  through  the  p55  TNF-R.  remains  unaf- 
fected, it may be postulated that LTo~ regulates GC forma- 
tion through the LT[3 receptor. This may be further sup- 
ported by the observed differences in splenic  architecture 
between the LTcl knockout mice which  completely lack 
distinct B and T cell areas, and the TNF0~ or the p55 TNF-R 
knockout mice which only lack organized B cell follicles. 
The responsible mechanism(s)  for these defects remains 
elusive, however, currently existing evidence suggests  that 
it may tie in defective cell trafficking because of defective 
adhesion molecule expression, as was  recently exemplified 
in  p55  TNF-R knockout mice lacking expression of the 
adhesion molecule MAdCAM-1  in their splenic marginal 
zone  (42).  Trafficking or differentiation defects may also 
explain  the  absence  of organized  FDC  networks  which 
may in turn explain the impaired formation of primary B 
cell follicles.  In addition to TNFot and LTot, the  CD40L, 
yet another member of the TNF family of ligands,  is also 
necessary for the formation of germinal centers mainly by 
regulating T  cell-dependent B  cell activation events  (43, 
44). Although TNFot is also known to mediate T-B cell in- 
teractions (45-48), promote differentiation of macrophages 
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adhesion  molecule  expression  on  follicular  dendritic  cells 
(52),  it remains to be determined whether one or more of 
these properties are critically involved in the regulation of 
primary B  cell follicles and germinal center formation. 
T  Cell-dependent  and  T  Cell-independent  Antibody  Re- 
sponses in TNFa Knockout Mice.  To investigate the role of 
TNFo~  in  TD  humoral  immune  responses  we  tested  the 
primary and  secondary  antibody response  of TNFcx-defi- 
cient mice to the TD antigen SRBC. Wild-type and TNFo~ 
knockout mice were immunized with SRBC on day 0 and 
15,  and serum antibody responses were determined on day 
7,  14,  and  23  using SRBC-specific ELISAs. As shown in 
Fig. 6, TNFcx-deficient mice exhibit severely impaired IgG 
and IgE antibody responses but show a normal level of IgM 
antibodies.  However, despite the observed absence of pri- 
mary B cell follicles and germinal centers, Ig class-switching 
could still occur. Defective antibody responses could be re- 
constituted by either human or murine mutant transmem- 
brahe TNFo~ transgene expression (Fig.  6). 
Humoral immune responses  were also  measured in wild- 
type, TNFel  -/- and TNFot transgene-reconstituted TN&x -/- 
mice, immunized with a different TD antigen, 2,4,6-trini- 
trophenyl-conjugated  keyhole limpet hemocyanin  (TNP- 
KLH). IgG1, IgG2a, IgG2b, IgG3, and IgE responses were 
readily  detectable  in  TNFoe  knockout  mice,  albeit  at  a 
1406  Role of TNFIx in Splenic Follicle Development Figure 5.  Follicular dendritic cell networks and germinal center formation in immunized TNFa +/+, TNFet -/-, and TNFa transgene-complemented 
TNFot -/- mice. Sections of spleens obtained 8 d after immunization with StLBC were stained with either FDC-M1  (a and b) or PNA (brown)  and anti- 
B220 (blue)  (c-f).  In TNFa +/+ control mice, clusters of FDC-Ml-positive cells (a) or PNA-positive cells (brown)  comprising the germinal centers (GC) 
(c), are detected. FDC networks (b) and germinal centers (d) are absent in spleens from TNFet -/-  mice, where only some small patches of PNA positive 
cells are observed around arterioles (d). In homozygous knockout mice reconstituted with a human TNFc~ transgene, large germinal centers are observed 
forming ectopically inside the T  cell-rich PALS and in close proximity to arterioles (e). Germinal center formation is completely restored in the spleens 
from transmembrane murine TNFoe transgene-complemented TNFot -/- mice, where typical germinal centers are seen, forming inside the B220-positive 
follicles at the periphery of the T  cell-rich PALS (f). Arrowheads denote central arterioles; original magnifications X 100. 
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cific ELISAs.  Sera were diluted 1:1,000 for measuring IgM and IgE antibodies, and 1:20,000 for measuring IgG-subclass  antibodies. Results are presented 
in means of duplicate data from individual mice. Open bars represent mean values for each group. Similar results were obtained when mice were immu- 
nized with 1 b~g TNP-KLH in CFA 
lower level in comparison to wild-type controls, 20 d  after 
the primary immunization (Fig. 7). However, upon secondary 
immunization the magnitude of the IgE and IgG isotype re- 
sponse was similar to wild-type controls. This was not the 
case  in  IgG2a responses which  were  found severely com- 
promised in  TNFc~ -/- mice in comparison to  the normal 
controls suggesting a  role for TNF(x in directing this spe- 
cific recombination. In addition, TNFc~-deficient mice ex- 
hibit enhanced TNP-specific IgM antibody titters in com- 
parison to the wild-type controls probably as a consequence 
of incomplete class switching. Reconstitution of the TNF(x 
deficiency in  the  TNFa -/-  X  Tg1278  and  TNF(x -/-  ￿ 
TgA86 double transgenic mice, normalizes antibody responses 
(Fig. 7).  Taken together, these results suggest that although 
isotype switching can still occur in the absence of germinal 
centers and  FDCs,  prolonged antibody responses are gen- 
erally impaired  in  TNF(x  knockout  mice,  most  probably 
because of a defect in sustained antigen presentation, Adju- 
vant-aided  immunization  (as  seen  in  the  TNP-KLH  ira- 
munization)  seems to compensate for this defect, probably 
by trapping the antigen in a local deposit and by reducing 
its rate of dispersal. 
Among cytokines, NK cell-derived TNF(x has been im- 
plicated in regulating humoral immune responses to TI an- 
tigens  (53).  The  ability of TNFa  knockout  mice  to  pro- 
duce  antibodies in response  to  TI  antigens, was  measured 
after immunization of mice by either a type 1  (TNP-LPS) 
or a  type  2  (TNP-Ficoll) TI  antigen.  In both  cases,  IgM 
antibody responses ofTNFe~ -/  mice were found similar to 
wild-type controls  (Fig.  8).  However,  anti-TNP  IgG  re- 
sponses to TNP-LPS were found slightly decreased 14 d af- 
ter immunization. As type I TI antigens are believed to be 
immunogenic  mainly through polyclonal B  cell activation 
(53), the decreased responses observed in TNF(x knockout 
mice  may reflect participation of TNF  in  this process.  In 
contrast,  TNFot  knockout  mice  mounted  enhanced  IgG 
responses  to  TNP-Ficoll  (Fig.  8  b)  which  may be  due  to 
the observed structural deficiencies in B  cell compartments 
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of TNFot  knockout  mice.  Indeed,  marginal  zone  B  cells 
have been implicated in mediating responses to type II TI 
antigens  (54,  55).  It  will  be  interesting  to  investigate 
whether  additional structural  perturbations  may be  local- 
ized in B  cell containing areas other than follicles, as for ex- 
ample in the marginal zone. 
In conclusion, our findings demonstrate the critical role 
of TNFct in LPS-mediated toxicity, anti-bacterial host de- 
fense  and  contact hypersensitivity reactions.  Furthermore, 
they establish a  critical requirement for this factor in pro- 
cesses regulating the formation of primary B  cell follicles, 
FDC networks and germinal centers and in the physiologi- 
cal maturation of the humoral immune response. These re- 
sults should prove useful in the further understanding of the 
biological consequences  of a  long term blockade of TNF 
functioning,  as a  means  of treating chronic  inflammatory 
and  autoimmune  pathology  in  human  patients.  TNFot 
knockout mice should also provide an important model for 
further analyzing the functions of B  cell follicles and FDCs 
in peripheral B  cell homing, survival, and differentiation. 
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